IFNG and lung carcinoma: On the other hand, Shurin et al. demonstrated that adoptive transfer of activin-A-treated DCs in both melanoma and lung carcinoma models inhibited tumor growth and enhanced the overall survival of tumor-bearing mice, partly through the generation of tumor-specific IFN-γ-producing T cells [49].